nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—CYP3A7—Tacrolimus—atopic dermatitis	0.0488	0.0605	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0488	0.0605	CbGbCtD
Lovastatin—CYP2C8—Mometasone—atopic dermatitis	0.0448	0.0556	CbGbCtD
Lovastatin—SLCO1A2—Prednisolone—atopic dermatitis	0.0379	0.0469	CbGbCtD
Lovastatin—CYP3A5—Tacrolimus—atopic dermatitis	0.0366	0.0454	CbGbCtD
Lovastatin—SLCO1A2—Hydrocortisone—atopic dermatitis	0.0359	0.0445	CbGbCtD
Lovastatin—SLCO1A2—Prednisone—atopic dermatitis	0.0358	0.0443	CbGbCtD
Lovastatin—CYP2C8—Loratadine—atopic dermatitis	0.0258	0.0319	CbGbCtD
Lovastatin—CYP3A4—Pimecrolimus—atopic dermatitis	0.024	0.0298	CbGbCtD
Lovastatin—ABCB1—Tacrolimus—atopic dermatitis	0.0238	0.0295	CbGbCtD
Lovastatin—SLCO1A2—Dexamethasone—atopic dermatitis	0.0223	0.0277	CbGbCtD
Lovastatin—CYP2C19—Loratadine—atopic dermatitis	0.0216	0.0268	CbGbCtD
Lovastatin—CYP2C19—Diphenhydramine—atopic dermatitis	0.0216	0.0268	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0199	0.0246	CbGbCtD
Lovastatin—CYP3A7—Hydrocortisone—atopic dermatitis	0.0199	0.0246	CbGbCtD
Lovastatin—ABCC2—Dexamethasone—atopic dermatitis	0.0185	0.0229	CbGbCtD
Lovastatin—CYP2C9—Diphenhydramine—atopic dermatitis	0.018	0.0223	CbGbCtD
Lovastatin—CYP2C9—Loratadine—atopic dermatitis	0.018	0.0223	CbGbCtD
Lovastatin—ABCB1—Loratadine—atopic dermatitis	0.0174	0.0216	CbGbCtD
Lovastatin—CYP2D6—Loratadine—atopic dermatitis	0.0164	0.0204	CbGbCtD
Lovastatin—CYP2D6—Diphenhydramine—atopic dermatitis	0.0164	0.0204	CbGbCtD
Lovastatin—ABCB1—Methylprednisolone—atopic dermatitis	0.0159	0.0198	CbGbCtD
Lovastatin—CYP3A5—Hydrocortisone—atopic dermatitis	0.0149	0.0185	CbGbCtD
Lovastatin—CYP2C8—Hydrocortisone—atopic dermatitis	0.0143	0.0178	CbGbCtD
Lovastatin—CYP3A4—Tacrolimus—atopic dermatitis	0.0143	0.0177	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.0124	0.0153	CbGbCtD
Lovastatin—CYP3A7—Dexamethasone—atopic dermatitis	0.0124	0.0153	CbGbCtD
Lovastatin—CYP2C19—Prednisone—atopic dermatitis	0.012	0.0148	CbGbCtD
Lovastatin—CYP3A4—Loratadine—atopic dermatitis	0.0104	0.013	CbGbCtD
Lovastatin—ABCB1—Betamethasone—atopic dermatitis	0.0104	0.0129	CbGbCtD
Lovastatin—ABCB1—Prednisolone—atopic dermatitis	0.0102	0.0127	CbGbCtD
Lovastatin—ABCB1—Hydrocortisone—atopic dermatitis	0.0097	0.012	CbGbCtD
Lovastatin—ABCB1—Prednisone—atopic dermatitis	0.00966	0.012	CbGbCtD
Lovastatin—CYP3A4—Methylprednisolone—atopic dermatitis	0.00955	0.0118	CbGbCtD
Lovastatin—CYP3A5—Dexamethasone—atopic dermatitis	0.00927	0.0115	CbGbCtD
Lovastatin—CYP2C8—Dexamethasone—atopic dermatitis	0.00891	0.011	CbGbCtD
Lovastatin—CYP2C19—Dexamethasone—atopic dermatitis	0.00748	0.00927	CbGbCtD
Lovastatin—CYP3A4—Triamcinolone—atopic dermatitis	0.00724	0.00898	CbGbCtD
Lovastatin—CYP2C9—Dexamethasone—atopic dermatitis	0.00621	0.00771	CbGbCtD
Lovastatin—CYP3A4—Betamethasone—atopic dermatitis	0.00621	0.0077	CbGbCtD
Lovastatin—CYP3A4—Prednisolone—atopic dermatitis	0.00613	0.0076	CbGbCtD
Lovastatin—ABCB1—Dexamethasone—atopic dermatitis	0.00603	0.00748	CbGbCtD
Lovastatin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00581	0.0072	CbGbCtD
Lovastatin—CYP3A4—Prednisone—atopic dermatitis	0.00579	0.00718	CbGbCtD
Lovastatin—CYP2D6—Dexamethasone—atopic dermatitis	0.00568	0.00705	CbGbCtD
Lovastatin—CYP3A4—Dexamethasone—atopic dermatitis	0.00361	0.00448	CbGbCtD
Lovastatin—HDAC2—Temsirolimus—Tacrolimus—atopic dermatitis	0.000901	0.164	CbGdCrCtD
Lovastatin—HDAC2—Everolimus—Tacrolimus—atopic dermatitis	0.000901	0.164	CbGdCrCtD
Lovastatin—HDAC2—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000901	0.164	CbGdCrCtD
Lovastatin—HDAC2—Sirolimus—Tacrolimus—atopic dermatitis	0.000901	0.164	CbGdCrCtD
Lovastatin—HDAC2—Everolimus—Pimecrolimus—atopic dermatitis	0.000901	0.164	CbGdCrCtD
Lovastatin—HDAC2—Sirolimus—Pimecrolimus—atopic dermatitis	0.000901	0.164	CbGdCrCtD
Lovastatin—ITGAL—Extracellular matrix organization—KLK7—atopic dermatitis	0.000784	0.0661	CbGpPWpGaD
Lovastatin—HDAC2—p75NTR negatively regulates cell cycle via SC1—NGF—atopic dermatitis	0.000718	0.0606	CbGpPWpGaD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—SELE—atopic dermatitis	0.000482	0.0406	CbGpPWpGaD
Lovastatin—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—PPARA—atopic dermatitis	0.000382	0.0323	CbGpPWpGaD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD8A—atopic dermatitis	0.000348	0.0294	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CTSE—atopic dermatitis	0.000342	0.0289	CbGpPWpGaD
Lovastatin—HDAC2—Hedgehog signaling events mediated by Gli proteins—KIF3A—atopic dermatitis	0.000328	0.0277	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—FCER2—atopic dermatitis	0.000257	0.0217	CbGpPWpGaD
Lovastatin—Dyspepsia—Tacrolimus—atopic dermatitis	0.000247	0.0014	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—CMA1—atopic dermatitis	0.000247	0.0208	CbGpPWpGaD
Lovastatin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000244	0.00139	CcSEcCtD
Lovastatin—Nausea—Loratadine—atopic dermatitis	0.000244	0.00139	CcSEcCtD
Lovastatin—Decreased appetite—Tacrolimus—atopic dermatitis	0.000244	0.00139	CcSEcCtD
Lovastatin—Fatigue—Tacrolimus—atopic dermatitis	0.000242	0.00137	CcSEcCtD
Lovastatin—Diarrhoea—Mometasone—atopic dermatitis	0.000241	0.00137	CcSEcCtD
Lovastatin—Constipation—Tacrolimus—atopic dermatitis	0.00024	0.00136	CcSEcCtD
Lovastatin—Pain—Tacrolimus—atopic dermatitis	0.00024	0.00136	CcSEcCtD
Lovastatin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000235	0.00133	CcSEcCtD
Lovastatin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000233	0.00132	CcSEcCtD
Lovastatin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000233	0.00132	CcSEcCtD
Lovastatin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000231	0.00131	CcSEcCtD
Lovastatin—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000231	0.00131	CcSEcCtD
Lovastatin—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.00023	0.00131	CcSEcCtD
Lovastatin—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.00023	0.00131	CcSEcCtD
Lovastatin—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00023	0.0013	CcSEcCtD
Lovastatin—Pancreatitis—Prednisone—atopic dermatitis	0.000225	0.00128	CcSEcCtD
Lovastatin—Vomiting—Mometasone—atopic dermatitis	0.000224	0.00127	CcSEcCtD
Lovastatin—Urticaria—Tacrolimus—atopic dermatitis	0.000223	0.00127	CcSEcCtD
Lovastatin—Rash—Mometasone—atopic dermatitis	0.000222	0.00126	CcSEcCtD
Lovastatin—Dermatitis—Mometasone—atopic dermatitis	0.000222	0.00126	CcSEcCtD
Lovastatin—Abdominal pain—Tacrolimus—atopic dermatitis	0.000222	0.00126	CcSEcCtD
Lovastatin—Body temperature increased—Tacrolimus—atopic dermatitis	0.000222	0.00126	CcSEcCtD
Lovastatin—Headache—Mometasone—atopic dermatitis	0.000221	0.00125	CcSEcCtD
Lovastatin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000219	0.00125	CcSEcCtD
Lovastatin—Erectile dysfunction—Prednisone—atopic dermatitis	0.000211	0.0012	CcSEcCtD
Lovastatin—Nausea—Mometasone—atopic dermatitis	0.000209	0.00119	CcSEcCtD
Lovastatin—ITGAL—Immune System—CTSE—atopic dermatitis	0.000208	0.0175	CbGpPWpGaD
Lovastatin—Vision blurred—Prednisolone—atopic dermatitis	0.000207	0.00118	CcSEcCtD
Lovastatin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000207	0.00117	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000204	0.00116	CcSEcCtD
Lovastatin—Asthenia—Tacrolimus—atopic dermatitis	0.000201	0.00114	CcSEcCtD
Lovastatin—Angioedema—Prednisolone—atopic dermatitis	0.000201	0.00114	CcSEcCtD
Lovastatin—Neuropathy peripheral—Prednisone—atopic dermatitis	0.0002	0.00114	CcSEcCtD
Lovastatin—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000199	0.00113	CcSEcCtD
Lovastatin—Pruritus—Tacrolimus—atopic dermatitis	0.000199	0.00113	CcSEcCtD
Lovastatin—Malaise—Prednisolone—atopic dermatitis	0.000198	0.00112	CcSEcCtD
Lovastatin—Dysgeusia—Triamcinolone—atopic dermatitis	0.000198	0.00112	CcSEcCtD
Lovastatin—Vertigo—Prednisolone—atopic dermatitis	0.000197	0.00112	CcSEcCtD
Lovastatin—Angioedema—Hydrocortisone—atopic dermatitis	0.000196	0.00111	CcSEcCtD
Lovastatin—Back pain—Triamcinolone—atopic dermatitis	0.000195	0.00111	CcSEcCtD
Lovastatin—Malaise—Hydrocortisone—atopic dermatitis	0.000193	0.0011	CcSEcCtD
Lovastatin—HDAC2—Circadian rythm related genes—RELB—atopic dermatitis	0.000193	0.0163	CbGpPWpGaD
Lovastatin—Vertigo—Hydrocortisone—atopic dermatitis	0.000193	0.00109	CcSEcCtD
Lovastatin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000192	0.00109	CcSEcCtD
Lovastatin—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000187	0.00106	CcSEcCtD
Lovastatin—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000187	0.00106	CcSEcCtD
Lovastatin—Alopecia—Dexamethasone—atopic dermatitis	0.000186	0.00106	CcSEcCtD
Lovastatin—Alopecia—Betamethasone—atopic dermatitis	0.000186	0.00106	CcSEcCtD
Lovastatin—Dizziness—Tacrolimus—atopic dermatitis	0.000186	0.00105	CcSEcCtD
Lovastatin—Discomfort—Prednisolone—atopic dermatitis	0.000185	0.00105	CcSEcCtD
Lovastatin—Angioedema—Triamcinolone—atopic dermatitis	0.000185	0.00105	CcSEcCtD
Lovastatin—Angioedema—Methylprednisolone—atopic dermatitis	0.000184	0.00105	CcSEcCtD
Lovastatin—HMGCR—Activation of gene expression by SREBF (SREBP)—PPARA—atopic dermatitis	0.000184	0.0155	CbGpPWpGaD
Lovastatin—Myalgia—Hydrocortisone—atopic dermatitis	0.000183	0.00104	CcSEcCtD
Lovastatin—Malaise—Triamcinolone—atopic dermatitis	0.000182	0.00103	CcSEcCtD
Lovastatin—Anxiety—Hydrocortisone—atopic dermatitis	0.000182	0.00103	CcSEcCtD
Lovastatin—Malaise—Methylprednisolone—atopic dermatitis	0.000182	0.00103	CcSEcCtD
Lovastatin—Vertigo—Triamcinolone—atopic dermatitis	0.000181	0.00103	CcSEcCtD
Lovastatin—Vertigo—Methylprednisolone—atopic dermatitis	0.000181	0.00103	CcSEcCtD
Lovastatin—Discomfort—Hydrocortisone—atopic dermatitis	0.00018	0.00102	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000179	0.00102	CcSEcCtD
Lovastatin—Vomiting—Tacrolimus—atopic dermatitis	0.000178	0.00101	CcSEcCtD
Lovastatin—Rash—Tacrolimus—atopic dermatitis	0.000177	0.001	CcSEcCtD
Lovastatin—Dermatitis—Tacrolimus—atopic dermatitis	0.000177	0.001	CcSEcCtD
Lovastatin—Headache—Tacrolimus—atopic dermatitis	0.000176	0.000999	CcSEcCtD
Lovastatin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000175	0.000994	CcSEcCtD
Lovastatin—Infection—Hydrocortisone—atopic dermatitis	0.000174	0.000988	CcSEcCtD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—SELE—atopic dermatitis	0.000172	0.0145	CbGpPWpGaD
Lovastatin—Myalgia—Triamcinolone—atopic dermatitis	0.000172	0.000977	CcSEcCtD
Lovastatin—Arthralgia—Methylprednisolone—atopic dermatitis	0.000172	0.000974	CcSEcCtD
Lovastatin—Myalgia—Methylprednisolone—atopic dermatitis	0.000172	0.000974	CcSEcCtD
Lovastatin—Anxiety—Methylprednisolone—atopic dermatitis	0.000171	0.000971	CcSEcCtD
Lovastatin—Flushing—Prednisone—atopic dermatitis	0.00017	0.000966	CcSEcCtD
Lovastatin—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00017	0.000966	CcSEcCtD
Lovastatin—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00017	0.000966	CcSEcCtD
Lovastatin—Discomfort—Triamcinolone—atopic dermatitis	0.00017	0.000965	CcSEcCtD
Lovastatin—Discomfort—Methylprednisolone—atopic dermatitis	0.00017	0.000963	CcSEcCtD
Lovastatin—Dry mouth—Triamcinolone—atopic dermatitis	0.000168	0.000955	CcSEcCtD
Lovastatin—Angioedema—Betamethasone—atopic dermatitis	0.000167	0.000951	CcSEcCtD
Lovastatin—Angioedema—Dexamethasone—atopic dermatitis	0.000167	0.000951	CcSEcCtD
Lovastatin—Anorexia—Hydrocortisone—atopic dermatitis	0.000167	0.000948	CcSEcCtD
Lovastatin—Nausea—Tacrolimus—atopic dermatitis	0.000167	0.000947	CcSEcCtD
Lovastatin—Confusional state—Methylprednisolone—atopic dermatitis	0.000166	0.000942	CcSEcCtD
Lovastatin—Malaise—Dexamethasone—atopic dermatitis	0.000165	0.000939	CcSEcCtD
Lovastatin—Malaise—Betamethasone—atopic dermatitis	0.000165	0.000939	CcSEcCtD
Lovastatin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000165	0.000936	CcSEcCtD
Lovastatin—Vertigo—Dexamethasone—atopic dermatitis	0.000165	0.000935	CcSEcCtD
Lovastatin—Vertigo—Betamethasone—atopic dermatitis	0.000165	0.000935	CcSEcCtD
Lovastatin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000164	0.000934	CcSEcCtD
Lovastatin—Infection—Triamcinolone—atopic dermatitis	0.000164	0.00093	CcSEcCtD
Lovastatin—Infection—Methylprednisolone—atopic dermatitis	0.000163	0.000928	CcSEcCtD
Lovastatin—Insomnia—Prednisolone—atopic dermatitis	0.000162	0.000921	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—KIF3A—atopic dermatitis	0.000162	0.0137	CbGpPWpGaD
Lovastatin—Alopecia—Prednisone—atopic dermatitis	0.000162	0.00092	CcSEcCtD
Lovastatin—Paraesthesia—Prednisolone—atopic dermatitis	0.000161	0.000914	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00016	0.000906	CcSEcCtD
Lovastatin—Insomnia—Hydrocortisone—atopic dermatitis	0.000158	0.000899	CcSEcCtD
Lovastatin—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000157	0.000893	CcSEcCtD
Lovastatin—Myalgia—Betamethasone—atopic dermatitis	0.000156	0.000886	CcSEcCtD
Lovastatin—Myalgia—Dexamethasone—atopic dermatitis	0.000156	0.000886	CcSEcCtD
Lovastatin—Anxiety—Betamethasone—atopic dermatitis	0.000156	0.000883	CcSEcCtD
Lovastatin—Anxiety—Dexamethasone—atopic dermatitis	0.000156	0.000883	CcSEcCtD
Lovastatin—HDAC2—Initiation of transcription and translation elongation at the HIV-1 LTR—NFKBIA—atopic dermatitis	0.000155	0.0131	CbGpPWpGaD
Lovastatin—Discomfort—Betamethasone—atopic dermatitis	0.000154	0.000876	CcSEcCtD
Lovastatin—Discomfort—Dexamethasone—atopic dermatitis	0.000154	0.000876	CcSEcCtD
Lovastatin—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000154	0.000875	CcSEcCtD
Lovastatin—Pain—Prednisolone—atopic dermatitis	0.000153	0.000871	CcSEcCtD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL13—atopic dermatitis	0.000153	0.0129	CbGpPWpGaD
Lovastatin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000152	0.000864	CcSEcCtD
Lovastatin—Fatigue—Hydrocortisone—atopic dermatitis	0.000151	0.000857	CcSEcCtD
Lovastatin—Vision blurred—Prednisone—atopic dermatitis	0.00015	0.000854	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00015	0.000853	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.00015	0.000851	CcSEcCtD
Lovastatin—Pain—Hydrocortisone—atopic dermatitis	0.00015	0.00085	CcSEcCtD
Lovastatin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.00015	0.00085	CcSEcCtD
Lovastatin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.00015	0.00085	CcSEcCtD
Lovastatin—Insomnia—Triamcinolone—atopic dermatitis	0.000149	0.000847	CcSEcCtD
Lovastatin—Insomnia—Methylprednisolone—atopic dermatitis	0.000149	0.000845	CcSEcCtD
Lovastatin—Infection—Betamethasone—atopic dermatitis	0.000149	0.000844	CcSEcCtD
Lovastatin—Infection—Dexamethasone—atopic dermatitis	0.000149	0.000844	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisone—atopic dermatitis	0.000148	0.000841	CcSEcCtD
Lovastatin—Paraesthesia—Triamcinolone—atopic dermatitis	0.000148	0.000841	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000148	0.000839	CcSEcCtD
Lovastatin—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000148	0.000839	CcSEcCtD
Lovastatin—Dyspnoea—Triamcinolone—atopic dermatitis	0.000147	0.000835	CcSEcCtD
Lovastatin—HMGCR—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atopic dermatitis	0.000147	0.0124	CbGpPWpGaD
Lovastatin—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000146	0.000832	CcSEcCtD
Lovastatin—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000146	0.000832	CcSEcCtD
Lovastatin—Angioedema—Prednisone—atopic dermatitis	0.000146	0.000828	CcSEcCtD
Lovastatin—Dyspepsia—Triamcinolone—atopic dermatitis	0.000145	0.000824	CcSEcCtD
Lovastatin—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000145	0.000822	CcSEcCtD
Lovastatin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000144	0.000819	CcSEcCtD
Lovastatin—Malaise—Prednisone—atopic dermatitis	0.000144	0.000817	CcSEcCtD
Lovastatin—Vertigo—Prednisone—atopic dermatitis	0.000143	0.000814	CcSEcCtD
Lovastatin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000143	0.000813	CcSEcCtD
Lovastatin—Anorexia—Betamethasone—atopic dermatitis	0.000143	0.00081	CcSEcCtD
Lovastatin—Anorexia—Dexamethasone—atopic dermatitis	0.000143	0.00081	CcSEcCtD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—KIF3A—atopic dermatitis	0.000142	0.012	CbGpPWpGaD
Lovastatin—Urticaria—Prednisolone—atopic dermatitis	0.000142	0.000809	CcSEcCtD
Lovastatin—Fatigue—Triamcinolone—atopic dermatitis	0.000142	0.000807	CcSEcCtD
Lovastatin—Fatigue—Methylprednisolone—atopic dermatitis	0.000142	0.000805	CcSEcCtD
Lovastatin—Pain—Triamcinolone—atopic dermatitis	0.000141	0.000801	CcSEcCtD
Lovastatin—ITGAL—Adaptive Immune System—KIF3A—atopic dermatitis	0.00014	0.0118	CbGpPWpGaD
Lovastatin—Urticaria—Hydrocortisone—atopic dermatitis	0.000139	0.00079	CcSEcCtD
Lovastatin—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000138	0.000786	CcSEcCtD
Lovastatin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000138	0.000786	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000136	0.000774	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000136	0.000774	CcSEcCtD
Lovastatin—Arthralgia—Prednisone—atopic dermatitis	0.000136	0.000772	CcSEcCtD
Lovastatin—Myalgia—Prednisone—atopic dermatitis	0.000136	0.000772	CcSEcCtD
Lovastatin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000136	0.000772	CcSEcCtD
Lovastatin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000136	0.00077	CcSEcCtD
Lovastatin—Anxiety—Prednisone—atopic dermatitis	0.000135	0.000769	CcSEcCtD
Lovastatin—Insomnia—Dexamethasone—atopic dermatitis	0.000135	0.000768	CcSEcCtD
Lovastatin—Insomnia—Betamethasone—atopic dermatitis	0.000135	0.000768	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000135	0.000764	CcSEcCtD
Lovastatin—Paraesthesia—Dexamethasone—atopic dermatitis	0.000134	0.000763	CcSEcCtD
Lovastatin—Paraesthesia—Betamethasone—atopic dermatitis	0.000134	0.000763	CcSEcCtD
Lovastatin—Discomfort—Prednisone—atopic dermatitis	0.000134	0.000762	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000132	0.00075	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL5—atopic dermatitis	0.000132	0.0111	CbGpPWpGaD
Lovastatin—Dyspepsia—Betamethasone—atopic dermatitis	0.000132	0.000748	CcSEcCtD
Lovastatin—Dyspepsia—Dexamethasone—atopic dermatitis	0.000132	0.000748	CcSEcCtD
Lovastatin—Urticaria—Triamcinolone—atopic dermatitis	0.000131	0.000744	CcSEcCtD
Lovastatin—Urticaria—Methylprednisolone—atopic dermatitis	0.000131	0.000742	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—SELE—atopic dermatitis	0.000131	0.011	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL5—atopic dermatitis	0.00013	0.011	CbGpPWpGaD
Lovastatin—Body temperature increased—Triamcinolone—atopic dermatitis	0.00013	0.00074	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisone—atopic dermatitis	0.00013	0.00074	CcSEcCtD
Lovastatin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.00013	0.000738	CcSEcCtD
Lovastatin—Decreased appetite—Dexamethasone—atopic dermatitis	0.00013	0.000738	CcSEcCtD
Lovastatin—Decreased appetite—Betamethasone—atopic dermatitis	0.00013	0.000738	CcSEcCtD
Lovastatin—Infection—Prednisone—atopic dermatitis	0.000129	0.000735	CcSEcCtD
Lovastatin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000129	0.000733	CcSEcCtD
Lovastatin—Fatigue—Dexamethasone—atopic dermatitis	0.000129	0.000732	CcSEcCtD
Lovastatin—Fatigue—Betamethasone—atopic dermatitis	0.000129	0.000732	CcSEcCtD
Lovastatin—ITGAL—Immune System—FCER1A—atopic dermatitis	0.000128	0.0108	CbGpPWpGaD
Lovastatin—Pain—Betamethasone—atopic dermatitis	0.000128	0.000726	CcSEcCtD
Lovastatin—Pain—Dexamethasone—atopic dermatitis	0.000128	0.000726	CcSEcCtD
Lovastatin—Asthenia—Hydrocortisone—atopic dermatitis	0.000126	0.000713	CcSEcCtD
Lovastatin—Anorexia—Prednisone—atopic dermatitis	0.000124	0.000705	CcSEcCtD
Lovastatin—Pruritus—Hydrocortisone—atopic dermatitis	0.000124	0.000703	CcSEcCtD
Lovastatin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000123	0.0007	CcSEcCtD
Lovastatin—Feeling abnormal—Betamethasone—atopic dermatitis	0.000123	0.0007	CcSEcCtD
Lovastatin—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000122	0.000695	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000122	0.000695	CcSEcCtD
Lovastatin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000121	0.00069	CcSEcCtD
Lovastatin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000121	0.000688	CcSEcCtD
Lovastatin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00012	0.00068	CcSEcCtD
Lovastatin—ITGAL—Immune System—MS4A2—atopic dermatitis	0.000119	0.0101	CbGpPWpGaD
Lovastatin—Urticaria—Dexamethasone—atopic dermatitis	0.000119	0.000675	CcSEcCtD
Lovastatin—Urticaria—Betamethasone—atopic dermatitis	0.000119	0.000675	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000119	0.000674	CcSEcCtD
Lovastatin—Dizziness—Prednisolone—atopic dermatitis	0.000119	0.000673	CcSEcCtD
Lovastatin—Asthenia—Triamcinolone—atopic dermatitis	0.000118	0.000672	CcSEcCtD
Lovastatin—Body temperature increased—Dexamethasone—atopic dermatitis	0.000118	0.000672	CcSEcCtD
Lovastatin—Body temperature increased—Betamethasone—atopic dermatitis	0.000118	0.000672	CcSEcCtD
Lovastatin—Abdominal pain—Betamethasone—atopic dermatitis	0.000118	0.000672	CcSEcCtD
Lovastatin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000118	0.000672	CcSEcCtD
Lovastatin—Asthenia—Methylprednisolone—atopic dermatitis	0.000118	0.00067	CcSEcCtD
Lovastatin—Insomnia—Prednisone—atopic dermatitis	0.000118	0.000669	CcSEcCtD
Lovastatin—Paraesthesia—Prednisone—atopic dermatitis	0.000117	0.000664	CcSEcCtD
Lovastatin—Pruritus—Triamcinolone—atopic dermatitis	0.000117	0.000662	CcSEcCtD
Lovastatin—Pruritus—Methylprednisolone—atopic dermatitis	0.000116	0.000661	CcSEcCtD
Lovastatin—ITGAL—Adaptive Immune System—CARD11—atopic dermatitis	0.000116	0.00978	CbGpPWpGaD
Lovastatin—Dizziness—Hydrocortisone—atopic dermatitis	0.000116	0.000658	CcSEcCtD
Lovastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000115	0.0097	CbGpPWpGaD
Lovastatin—Dyspepsia—Prednisone—atopic dermatitis	0.000115	0.000651	CcSEcCtD
Lovastatin—Decreased appetite—Prednisone—atopic dermatitis	0.000113	0.000643	CcSEcCtD
Lovastatin—Rash—Prednisolone—atopic dermatitis	0.000113	0.000642	CcSEcCtD
Lovastatin—Dermatitis—Prednisolone—atopic dermatitis	0.000113	0.000641	CcSEcCtD
Lovastatin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000113	0.000639	CcSEcCtD
Lovastatin—Fatigue—Prednisone—atopic dermatitis	0.000112	0.000638	CcSEcCtD
Lovastatin—Headache—Prednisolone—atopic dermatitis	0.000112	0.000638	CcSEcCtD
Lovastatin—Constipation—Prednisone—atopic dermatitis	0.000111	0.000633	CcSEcCtD
Lovastatin—Vomiting—Hydrocortisone—atopic dermatitis	0.000111	0.000632	CcSEcCtD
Lovastatin—Rash—Hydrocortisone—atopic dermatitis	0.00011	0.000627	CcSEcCtD
Lovastatin—Dermatitis—Hydrocortisone—atopic dermatitis	0.00011	0.000626	CcSEcCtD
Lovastatin—Headache—Hydrocortisone—atopic dermatitis	0.00011	0.000623	CcSEcCtD
Lovastatin—Dizziness—Triamcinolone—atopic dermatitis	0.000109	0.000619	CcSEcCtD
Lovastatin—Dizziness—Methylprednisolone—atopic dermatitis	0.000109	0.000618	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisone—atopic dermatitis	0.000107	0.00061	CcSEcCtD
Lovastatin—Asthenia—Dexamethasone—atopic dermatitis	0.000107	0.00061	CcSEcCtD
Lovastatin—Asthenia—Betamethasone—atopic dermatitis	0.000107	0.00061	CcSEcCtD
Lovastatin—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000107	0.000605	CcSEcCtD
Lovastatin—Nausea—Prednisolone—atopic dermatitis	0.000106	0.000605	CcSEcCtD
Lovastatin—ITGAL—Immune System—DEFB1—atopic dermatitis	0.000106	0.00897	CbGpPWpGaD
Lovastatin—Pruritus—Dexamethasone—atopic dermatitis	0.000106	0.000601	CcSEcCtD
Lovastatin—Pruritus—Betamethasone—atopic dermatitis	0.000106	0.000601	CcSEcCtD
Lovastatin—Vomiting—Triamcinolone—atopic dermatitis	0.000105	0.000595	CcSEcCtD
Lovastatin—Vomiting—Methylprednisolone—atopic dermatitis	0.000105	0.000594	CcSEcCtD
Lovastatin—Nausea—Hydrocortisone—atopic dermatitis	0.000104	0.000591	CcSEcCtD
Lovastatin—Rash—Triamcinolone—atopic dermatitis	0.000104	0.00059	CcSEcCtD
Lovastatin—Dermatitis—Triamcinolone—atopic dermatitis	0.000104	0.00059	CcSEcCtD
Lovastatin—Rash—Methylprednisolone—atopic dermatitis	0.000104	0.000589	CcSEcCtD
Lovastatin—Dermatitis—Methylprednisolone—atopic dermatitis	0.000104	0.000588	CcSEcCtD
Lovastatin—Urticaria—Prednisone—atopic dermatitis	0.000103	0.000588	CcSEcCtD
Lovastatin—Headache—Triamcinolone—atopic dermatitis	0.000103	0.000587	CcSEcCtD
Lovastatin—Headache—Methylprednisolone—atopic dermatitis	0.000103	0.000585	CcSEcCtD
Lovastatin—Abdominal pain—Prednisone—atopic dermatitis	0.000103	0.000585	CcSEcCtD
Lovastatin—Body temperature increased—Prednisone—atopic dermatitis	0.000103	0.000585	CcSEcCtD
Lovastatin—Diarrhoea—Betamethasone—atopic dermatitis	0.000102	0.000581	CcSEcCtD
Lovastatin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000102	0.000581	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—IL5—atopic dermatitis	9.9e-05	0.00835	CbGpPWpGaD
Lovastatin—Dizziness—Betamethasone—atopic dermatitis	9.89e-05	0.000562	CcSEcCtD
Lovastatin—Dizziness—Dexamethasone—atopic dermatitis	9.89e-05	0.000562	CcSEcCtD
Lovastatin—Nausea—Triamcinolone—atopic dermatitis	9.79e-05	0.000556	CcSEcCtD
Lovastatin—Nausea—Methylprednisolone—atopic dermatitis	9.77e-05	0.000555	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	9.63e-05	0.00813	CbGpPWpGaD
Lovastatin—Hypersensitivity—Prednisone—atopic dermatitis	9.6e-05	0.000545	CcSEcCtD
Lovastatin—Vomiting—Betamethasone—atopic dermatitis	9.51e-05	0.00054	CcSEcCtD
Lovastatin—Vomiting—Dexamethasone—atopic dermatitis	9.51e-05	0.00054	CcSEcCtD
Lovastatin—Rash—Dexamethasone—atopic dermatitis	9.43e-05	0.000536	CcSEcCtD
Lovastatin—Rash—Betamethasone—atopic dermatitis	9.43e-05	0.000536	CcSEcCtD
Lovastatin—Dermatitis—Dexamethasone—atopic dermatitis	9.42e-05	0.000535	CcSEcCtD
Lovastatin—Dermatitis—Betamethasone—atopic dermatitis	9.42e-05	0.000535	CcSEcCtD
Lovastatin—Headache—Dexamethasone—atopic dermatitis	9.37e-05	0.000532	CcSEcCtD
Lovastatin—Headache—Betamethasone—atopic dermatitis	9.37e-05	0.000532	CcSEcCtD
Lovastatin—Asthenia—Prednisone—atopic dermatitis	9.35e-05	0.000531	CcSEcCtD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL4—atopic dermatitis	9.28e-05	0.00783	CbGpPWpGaD
Lovastatin—Pruritus—Prednisone—atopic dermatitis	9.22e-05	0.000523	CcSEcCtD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	9.08e-05	0.00766	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—CASP1—atopic dermatitis	8.97e-05	0.00757	CbGpPWpGaD
Lovastatin—Diarrhoea—Prednisone—atopic dermatitis	8.91e-05	0.000506	CcSEcCtD
Lovastatin—Nausea—Dexamethasone—atopic dermatitis	8.89e-05	0.000505	CcSEcCtD
Lovastatin—Nausea—Betamethasone—atopic dermatitis	8.89e-05	0.000505	CcSEcCtD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—NGF—atopic dermatitis	8.87e-05	0.00748	CbGpPWpGaD
Lovastatin—HDAC2—Levonorgestrel—Hydrocortisone—atopic dermatitis	8.72e-05	0.0159	CbGdCrCtD
Lovastatin—Dizziness—Prednisone—atopic dermatitis	8.61e-05	0.000489	CcSEcCtD
Lovastatin—ITGAL—Immune System—KIF3A—atopic dermatitis	8.5e-05	0.00717	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—NFKBIA—atopic dermatitis	8.3e-05	0.007	CbGpPWpGaD
Lovastatin—Vomiting—Prednisone—atopic dermatitis	8.28e-05	0.00047	CcSEcCtD
Lovastatin—Rash—Prednisone—atopic dermatitis	8.21e-05	0.000466	CcSEcCtD
Lovastatin—Dermatitis—Prednisone—atopic dermatitis	8.21e-05	0.000466	CcSEcCtD
Lovastatin—HMGCR—PPARA activates gene expression—PPARA—atopic dermatitis	8.18e-05	0.0069	CbGpPWpGaD
Lovastatin—Headache—Prednisone—atopic dermatitis	8.16e-05	0.000463	CcSEcCtD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	8.1e-05	0.00684	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	8.07e-05	0.00681	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	8.01e-05	0.00675	CbGpPWpGaD
Lovastatin—Nausea—Prednisone—atopic dermatitis	7.74e-05	0.000439	CcSEcCtD
Lovastatin—ITGAL—Adaptive Immune System—CD79A—atopic dermatitis	7.68e-05	0.00648	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—MAPK8—atopic dermatitis	7.62e-05	0.00643	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—NFKBIA—atopic dermatitis	7.31e-05	0.00617	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—STAT6—atopic dermatitis	7.22e-05	0.0061	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.09e-05	0.00598	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CARD11—atopic dermatitis	7.03e-05	0.00593	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—NPS—atopic dermatitis	6.85e-05	0.00578	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.77e-05	0.00571	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—IFNG—atopic dermatitis	6.52e-05	0.0055	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.46e-05	0.00545	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	6.28e-05	0.0053	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD8A—atopic dermatitis	6.19e-05	0.00522	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.06e-05	0.00512	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	5.94e-05	0.00501	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	5.88e-05	0.00496	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—IL2—atopic dermatitis	5.79e-05	0.00489	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IFNG—atopic dermatitis	5.61e-05	0.00473	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	5.6e-05	0.00472	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	5.58e-05	0.00471	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	5.52e-05	0.00465	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CASP1—atopic dermatitis	5.48e-05	0.00462	CbGpPWpGaD
Lovastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	5.41e-05	0.00456	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	5.32e-05	0.00449	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—CXCL8—atopic dermatitis	5.22e-05	0.0044	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL5—atopic dermatitis	5.19e-05	0.00438	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	5.12e-05	0.00432	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL13—atopic dermatitis	5.08e-05	0.00428	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	5.06e-05	0.00427	CbGpPWpGaD
Lovastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	5.05e-05	0.00426	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL2—atopic dermatitis	4.99e-05	0.00421	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—KIF3A—atopic dermatitis	4.98e-05	0.0042	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—TLR2—atopic dermatitis	4.95e-05	0.00418	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—NFKBIA—atopic dermatitis	4.8e-05	0.00405	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	4.67e-05	0.00394	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD79A—atopic dermatitis	4.66e-05	0.00393	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—MAPK8—atopic dermatitis	4.59e-05	0.00387	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—MAPK8—atopic dermatitis	4.59e-05	0.00387	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	4.38e-05	0.00369	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL5—atopic dermatitis	4.34e-05	0.00367	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—atopic dermatitis	4.12e-05	0.00348	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.09e-05	0.00345	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.06e-05	0.00343	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—PPARA—atopic dermatitis	4.04e-05	0.00341	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SELE—atopic dermatitis	4.01e-05	0.00339	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL18—atopic dermatitis	3.81e-05	0.00321	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—IL2—atopic dermatitis	3.78e-05	0.00319	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD8A—atopic dermatitis	3.75e-05	0.00317	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD4—atopic dermatitis	3.55e-05	0.003	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.49e-05	0.00295	CbGpPWpGaD
Lovastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.33e-05	0.00281	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—NGF—atopic dermatitis	3.26e-05	0.00275	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL10—atopic dermatitis	3.18e-05	0.00268	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL4—atopic dermatitis	3.09e-05	0.00261	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL5—atopic dermatitis	3.04e-05	0.00257	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	3.04e-05	0.00256	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GLB1—atopic dermatitis	3.01e-05	0.00254	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	2.93e-05	0.00247	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—NFKBIA—atopic dermatitis	2.91e-05	0.00246	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ADSL—atopic dermatitis	2.89e-05	0.00244	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GLB1—atopic dermatitis	2.88e-05	0.00243	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—NFKBIA—atopic dermatitis	2.69e-05	0.00227	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CASP8—atopic dermatitis	2.62e-05	0.00221	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.6e-05	0.0022	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FCER2—atopic dermatitis	2.55e-05	0.00215	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GLB1—atopic dermatitis	2.46e-05	0.00207	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL22—atopic dermatitis	2.37e-05	0.002	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.37e-05	0.002	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ADSL—atopic dermatitis	2.36e-05	0.00199	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—MAPK8—atopic dermatitis	2.24e-05	0.00189	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IFNG—atopic dermatitis	2.23e-05	0.00188	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.23e-05	0.00188	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	2.2e-05	0.00185	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.2e-05	0.00185	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD4—atopic dermatitis	2.16e-05	0.00182	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL27—atopic dermatitis	2.11e-05	0.00178	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GLB1—atopic dermatitis	2.09e-05	0.00176	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.01e-05	0.00169	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ADSL—atopic dermatitis	2e-05	0.00169	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1B—atopic dermatitis	1.99e-05	0.00168	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL2—atopic dermatitis	1.98e-05	0.00167	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC11A1—atopic dermatitis	1.93e-05	0.00163	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL17—atopic dermatitis	1.89e-05	0.0016	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.87e-05	0.00158	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—MAPK8—atopic dermatitis	1.83e-05	0.00154	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GLB1—atopic dermatitis	1.82e-05	0.00154	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.79e-05	0.00151	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ADSL—atopic dermatitis	1.74e-05	0.00147	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.74e-05	0.00147	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GLB1—atopic dermatitis	1.7e-05	0.00143	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—MAPK8—atopic dermatitis	1.69e-05	0.00142	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KIF3A—atopic dermatitis	1.69e-05	0.00142	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.67e-05	0.00141	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.66e-05	0.0014	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.64e-05	0.00139	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.63e-05	0.00138	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ADSL—atopic dermatitis	1.63e-05	0.00137	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GLB1—atopic dermatitis	1.56e-05	0.00131	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CMA1—atopic dermatitis	1.53e-05	0.00129	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL11—atopic dermatitis	1.53e-05	0.00129	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ADSL—atopic dermatitis	1.49e-05	0.00126	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT6—atopic dermatitis	1.44e-05	0.00121	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—atopic dermatitis	1.43e-05	0.00121	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.43e-05	0.0012	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.37e-05	0.00116	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.33e-05	0.00112	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.26e-05	0.00106	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR3—atopic dermatitis	1.24e-05	0.00105	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—atopic dermatitis	1.21e-05	0.00102	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.2e-05	0.00101	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—atopic dermatitis	1.17e-05	0.000983	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2—atopic dermatitis	1.16e-05	0.000981	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.15e-05	0.000968	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.13e-05	0.000957	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.11e-05	0.00094	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NPS—atopic dermatitis	1.11e-05	0.000936	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TAC1—atopic dermatitis	1.11e-05	0.000936	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCR3—atopic dermatitis	1.09e-05	0.000918	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.08e-05	0.000915	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—atopic dermatitis	1.08e-05	0.00091	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.08e-05	0.00091	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GLB1—atopic dermatitis	1.03e-05	0.000871	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL5—atopic dermatitis	1.03e-05	0.00087	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—PPARA—atopic dermatitis	1.01e-05	0.000849	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ADSL—atopic dermatitis	9.9e-06	0.000835	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PPARA—atopic dermatitis	9.78e-06	0.000825	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CCR5—atopic dermatitis	9.74e-06	0.000822	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GLB1—atopic dermatitis	8.94e-06	0.000754	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL10—atopic dermatitis	8.8e-06	0.000742	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ADSL—atopic dermatitis	8.57e-06	0.000723	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GLB1—atopic dermatitis	7.98e-06	0.000673	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PPARA—atopic dermatitis	7.98e-06	0.000673	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GLB1—atopic dermatitis	7.79e-06	0.000657	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ADSL—atopic dermatitis	7.65e-06	0.000645	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL5—atopic dermatitis	7.57e-06	0.000639	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	7.54e-06	0.000636	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ADSL—atopic dermatitis	7.47e-06	0.00063	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GLB1—atopic dermatitis	7.34e-06	0.000619	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GLB1—atopic dermatitis	7.28e-06	0.000614	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADSL—atopic dermatitis	7.04e-06	0.000594	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NGF—atopic dermatitis	7.01e-06	0.000592	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADSL—atopic dermatitis	6.98e-06	0.000589	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR5—atopic dermatitis	6.82e-06	0.000575	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PPARA—atopic dermatitis	6.78e-06	0.000572	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.52e-06	0.00055	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD4—atopic dermatitis	6.12e-06	0.000516	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.97e-06	0.000503	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PPARA—atopic dermatitis	5.9e-06	0.000498	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.82e-06	0.000491	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NFKBIA—atopic dermatitis	5.78e-06	0.000488	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARA—atopic dermatitis	5.51e-06	0.000465	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.4e-06	0.000455	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.3e-06	0.000447	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARA—atopic dermatitis	5.05e-06	0.000426	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GLB1—atopic dermatitis	4.8e-06	0.000405	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARA—atopic dermatitis	4.63e-06	0.000391	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADSL—atopic dermatitis	4.6e-06	0.000388	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—atopic dermatitis	4.12e-06	0.000348	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—atopic dermatitis	3.94e-06	0.000333	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK8—atopic dermatitis	3.63e-06	0.000306	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARA—atopic dermatitis	3.35e-06	0.000283	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—atopic dermatitis	3.31e-06	0.000279	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARA—atopic dermatitis	2.9e-06	0.000245	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARA—atopic dermatitis	2.59e-06	0.000219	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARA—atopic dermatitis	2.53e-06	0.000213	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.38e-06	0.000201	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARA—atopic dermatitis	2.36e-06	0.000199	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—atopic dermatitis	2.32e-06	0.000195	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.56e-06	0.000131	CbGpPWpGaD
